The effects of alcohol metabolism on hepatic and cardiac energy state and function
酒精代谢对肝脏和心脏能量状态和功能的影响
基本信息
- 批准号:10506788
- 负责人:
- 金额:$ 14.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-08-10 至 2027-07-31
- 项目状态:未结题
- 来源:
- 关键词:ATP phosphohydrolaseAcetaldehydeAcetate-CoA LigaseAcetatesAcetyl Coenzyme AAcuteAffectAlcohol abuseAlcohol consumptionAlcohol dehydrogenaseAlcoholic CardiomyopathyAlcoholic Fatty LiverAlcoholsBiochemical ReactionBlood CirculationBlood PressureCardiacCardiac MyocytesCardiac healthCardiovascular DiseasesChronicCirrhosisCitric Acid CycleCoenzyme AConsumptionCytosolDataDevelopmentDietDoctor of MedicineDoctor of PhilosophyDoseDrug usageEFRACEchocardiographyEnzymesEthanolEthanol MetabolismFunctional disorderFutureHeartHeart DiseasesHeart failureHepaticHumanHyperlipidemiaHypertensionImpairmentIn VitroInfusion proceduresKnock-outKnockout MiceLeadLearningLipidsLiquid substanceLiverLiver CirrhosisMalonyl Coenzyme AMediatingMetabolicMetabolismMitochondriaMusMyocardial dysfunctionNADHNonesterified Fatty AcidsOrganOxidation-ReductionOxidesPerfusionPeripheralPredispositionProcessProductionProtein IsoformsProtocols documentationRodentRoleTechniquesTissuesTracerTrainingTriglyceridesUnited StatesWild Type Mousealcohol effectalcohol responsealdehyde dehydrogenaseschronic alcohol ingestiondietary controlexperimental studyfatty acid oxidationfatty liver diseaseheart functionheart metabolismin vivoinsightlipid biosynthesismetabolic abnormality assessmentmetabolomicsnoveloxidationresponseskills
项目摘要
Project Summary/Abstract
Alcohol is the most commonly used drug in the United States and its use is on the rise. Alcohol abuse can
result in alcoholic fatty liver disease, and even cirrhosis, as the majority of alcohol is metabolized by the liver
during first pass metabolism. Alcohol is primarily metabolized in the liver through two enzymatic reactions
(alcohol dehydrogenase and aldehyde dehydrogenase 2) that each reduce an NAD+ to NADH, contributing to a
reduced redox state. Alcohol consumption reduces the redox state (greater NADH/ NAD+ ratio) which may
impair β-oxidation and the TCA cycle. These factors may result in a reduction in fatty acid oxidation and the
accumulation of lipids. Metabolic mechanisms in the liver may also use acetate as substrate to contribute to de
novo lipogenesis, further contributing to alcoholic fatty liver disease. However, as much as 80% of the acetate
produced during alcohol metabolism escapes the liver and can be used by peripheral tissues or organs such
as the heart. The heart is also severely affected by alcohol abuse, which can lead to cardiac dysfunction and
the development of various cardiovascular diseases, such as alcoholic cardiomyopathy. In the heart, acetate
interferes with fatty acid oxidation, which results in lower ATP concentrations, as well as the accumulation of
triglycerides. Acetate may impair the oxidation of free fatty acids (FFAs) as fuel, not through the inhibition of
CPT via malonyl-CoA production, but by metabolic mechanisms outcompeting CPT for free CoAs therefore
resulting in the limitation of FFAs entry into the mitochondria for oxidation. Administering acetate in in vitro
(heart perfusions) and in vivo infusion experiments results in an energy deficit through a mechanism that has
yet to be elucidated. It is possible that this energy deficit, and lipid accumulation, in the heart are contributing to
cardiac dysfunction. The aim of this proposal is to examine these particular metabolic mechanisms and
determine whether they are responsible for the alcohol induced energy deficit in the heart. This proposal will
also determine whether these mechanisms are responsible for mediating alcohol induced cardiac dysfunction.
A secondary aim is to determine, through the use of tracers, how chronic alcohol consumption changes
overtime and how the liver and heart metabolize and use alcohol metabolites.
项目总结/文摘
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Justin Fletcher其他文献
Justin Fletcher的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Justin Fletcher', 18)}}的其他基金
The effects of alcohol metabolism on hepatic and cardiac energy state and function
酒精代谢对肝脏和心脏能量状态和功能的影响
- 批准号:
10679083 - 财政年份:2022
- 资助金额:
$ 14.09万 - 项目类别:
Energy Sensors and the Regulation of the TCA Cycle in the Liver
能量传感器和肝脏 TCA 循环的调节
- 批准号:
9439926 - 财政年份:2016
- 资助金额:
$ 14.09万 - 项目类别:
Energy Sensors and the Regulation of the TCA Cycle in the Liver
能量传感器和肝脏 TCA 循环的调节
- 批准号:
9122043 - 财政年份:2016
- 资助金额:
$ 14.09万 - 项目类别:
相似海外基金
An enzyme-based assay for the detection of acetaldehyde-protein adducts
用于检测乙醛-蛋白质加合物的酶测定法
- 批准号:
10760201 - 财政年份:2023
- 资助金额:
$ 14.09万 - 项目类别:
Dissecting the role of acetaldehyde in oral carcinogenesis
剖析乙醛在口腔癌发生中的作用
- 批准号:
10345780 - 财政年份:2022
- 资助金额:
$ 14.09万 - 项目类别:
Dissecting the role of acetaldehyde in oral carcinogenesis
剖析乙醛在口腔癌发生中的作用
- 批准号:
10706454 - 财政年份:2022
- 资助金额:
$ 14.09万 - 项目类别:
Identification of mutation patterns induced by acetaldehyde exposure
乙醛暴露引起的突变模式的鉴定
- 批准号:
20K17047 - 财政年份:2020
- 资助金额:
$ 14.09万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
RUI: Collaborative: Cycling of ethanol and acetaldehyde in coastal waters
RUI:合作:沿海水域乙醇和乙醛的循环
- 批准号:
2022184 - 财政年份:2020
- 资助金额:
$ 14.09万 - 项目类别:
Standard Grant
Reconsideration of the drinking habit of alcoholic liver disease patients from the viewpoint of acetaldehyde-derived advanced glycation end products
从乙醛衍生晚期糖基化终末产物角度重新思考酒精性肝病患者饮酒习惯
- 批准号:
19K11803 - 财政年份:2019
- 资助金额:
$ 14.09万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Pathogenic Role of Malondialdehyde-Acetaldehyde Adducts in Rheumatoid Arthritis
丙二醛-乙醛加合物在类风湿性关节炎中的致病作用
- 批准号:
10421254 - 财政年份:2019
- 资助金额:
$ 14.09万 - 项目类别:
Pathogenic Role of Malondialdehyde-Acetaldehyde Adducts in Rheumatoid Arthritis
丙二醛-乙醛加合物在类风湿性关节炎中的致病作用
- 批准号:
10045500 - 财政年份:2019
- 资助金额:
$ 14.09万 - 项目类别:
Pathogenic Role of Malondialdehyde-Acetaldehyde Adducts in Rheumatoid Arthritis
丙二醛-乙醛加合物在类风湿性关节炎中的致病作用
- 批准号:
10516090 - 财政年份:2019
- 资助金额:
$ 14.09万 - 项目类别:
Analysis of the molecular mechanism to repair acetaldehyde-induced DNA damage
修复乙醛所致DNA损伤的分子机制分析
- 批准号:
17K17846 - 财政年份:2017
- 资助金额:
$ 14.09万 - 项目类别:
Grant-in-Aid for Young Scientists (B)














{{item.name}}会员




